Imaging the pH evolution of an acute kidney injury model by means of iopamidol, a MRI-CEST pH-responsive contrast agent

Magnetic Resonance in Medicine

Volumn 70, Issue 3, 2013, Pages 859-864

  Longo, Dario Livio ^a   Busato, Alice ^a   Lanzardo, Stefania ^a   Antico, Federica ^b   Aime, Silvio ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

acute kidney injury; chemical exchange saturation transfer; glycerol; iopamidol; pH; responsive contrast agent

Indexed keywords

GLYCEROL; MAGNETIC RESONANCE IMAGING; PH; UREA;

ACUTE KIDNEY INJURY; BLOOD UREA NITROGENS; CHEMICAL EXCHANGE SATURATION TRANSFER; CONTRAST AGENT; CONTROL GROUPS; IOPAMIDOL; PH-RESPONSIVE; RENAL FAILURE;

DAMAGE DETECTION;

GLYCEROL; IOPAMIDOL; CONTRAST MEDIUM;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HISTOLOGY; IN VIVO STUDY; KIDNEY INJURY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PH; RENOGRAPHY; RHABDOMYOLYSIS; UREA NITROGEN BLOOD LEVEL; ANIMAL; DIAGNOSTIC USE; METABOLISM; PATHOPHYSIOLOGY;

ACUTE KIDNEY INJURY; ANIMALS; CONTRAST MEDIA; HYDROGEN-ION CONCENTRATION; IOPAMIDOL; MAGNETIC RESONANCE IMAGING; MICE;

EID: 84883242235     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.24513     Document Type: Article

References (34)

1. Pereira PC, Miranda DM, Oliveira EA, Silva AC,. Molecular pathophysiology of renal tubular acidosis. Curr Genomics 2009; 10: 51-59.
2. Lieberthal W, Nigam SK,. Acute renal failure. II. Experimental models of acute renal failure: imperfect but indispensable. Am J Physiol Renal Physiol 2000; 278: F1-F12.
3. Vanholder R, Sever MS, Erek E, Lameire N,. Rhabdomyolysis. J Am Soc Nephrol 2000; 11: 1553-1561.
4. Tracz MJ, Alam J, Nath KA,. Physiology and pathophysiology of heme: implications for kidney disease. J Am Soc Nephrol 2007; 18: 414-420.
5. Paragas N, Qiu A, Zhang Q, et al. The Ngal reporter mouse detects the response of the kidney to injury in real time. Nat Med 2011; 17: 216-222.
6. De Leon-Rodriguez LM, Lubag AJ, Malloy CR, Martinez GV, Gillies RJ, Sherry AD,. Responsive MRI agents for sensing metabolism in vivo. Acc Chem Res 2009; 42: 948-957.
7. Terreno E, Dastrù W, Delli Castelli D, Gianolio E, Geninatti Crich S, Longo D, Aime S,. Advances in metal-based probes for MR molecular imaging applications. Curr Med Chem 2010; 17: 3684-3700.
8. Gringeri CV, Menchise V, Rizzitelli S, Cittadino E, Catanzaro V, Dati G, Chaabane L, Digilio G, Aime S,. Novel Gd(III)-based probes for MR molecular imaging of matrix metalloproteinases. Contrast Media Mol Imaging 2012; 7: 175-184.
9. Raghunand N, Howison C, Sherry AD, Zhang S, Gillies RJ,. Renal and systemic pH imaging by contrast-enhanced MRI. Magn Reson Med 2003; 49: 249-257.
10. Martinez GV, Zhang X, García-Martín ML, Morse DL, Woods M, Sherry AD, Gillies RJ,. Imaging the extracellular pH of tumors by MRI after injection of a single cocktail of T1 and T2 contrast agents. NMR Biomed 2011; 24: 1380-1391.
11. Garcia-Martin ML, Herigault G, Remy C, Farion R, Ballesteros P, Coles JA, Cerdan S, Ziegler A,. Mapping extracellular pH in rat brain gliomas in vivo by 1H magnetic resonance spectroscopic imaging: comparison with maps of metabolites. Cancer Res 2001; 1: 6524-6531.
12. Gallagher FA, Kettunen MI, Day SE, et al. Magnetic resonance imaging of pH in vivo using hyperpolarized 13C labelled bicarbonate. Nature 2008; 453: 940-943.
13. Ward KM, Balaban RS,. Determination of pH using water protons and chemical exchange dependent saturation transfer (CEST). Magn Reson Med 2000; 44: 799-802.
14. Hancu I, Dixon WT, Woods M, Vinogradov E, Sherry AD, Lenkinski RE,. CEST and PARACEST MR contrast agents. Acta Radiol 2010; 51: 910-923.
15. Terreno E, Castelli DD, Aime S,. Encoding the frequency dependence in MRI contrast media: the emerging class of CEST agents. Contrast Media Mol Imaging 2010; 5: 78-98.
16. Sun PZ, Wang E, Cheung JS,. Imaging acute ischemic tissue acidosis with pH-sensitive endogenous amide proton transfer (APT) MRI-correction of tissue relaxation and concomitant RF irradiation effects toward mapping quantitative cerebral tissue pH. Neuroimage 2012; 60: 1-6.
17. Sun PZ, Cheung JS, Wang E, Lo EH,. Association between pH-weighted endogenous amide proton chemical exchange saturation transfer MRI and tissue lactic acidosis during acute ischemic stroke. J Cereb Blood Flow Metab 2011; 31: 1743-1750.
18. Delli Castelli D, Terreno E, Aime S,. Yb(III)-HPDO3A: a dual pH- and temperature-responsive CEST agent. Angew Chem Int Ed Engl 2011; 50: 1798-1800.
19. Torres E, Mainini F, Napolitano R, Fedeli F, Cavalli R, Aime S, Terreno E,. Improved paramagnetic liposomes for MRI visualization of pH triggered release. J Control Release 2011; 154: 196-202.
20. Sheth VR, Li Y, Chen LQ, Howison CM, Flask CA, Pagel MD,. Measuring in vivo tumor pHe with CEST-FISP MRI. Magn Reson Med 2012; 67: 760-768.
21. Liu G, Li Y, Sheth VR, Pagel MD,. Imaging in vivo extracellular pH with a single paramagnetic chemical exchange saturation transfer magnetic resonance imaging contrast agent. Mol Imaging 2012; 11: 47-57.
22. Pikkemaat JA, Wegh RT, Lamerichs R, et al. Dendritic PARACEST contrast agents for magnetic resonance imaging. Contrast Media Mol Imaging 2007; 2: 229-239.
23. Aime S, Barge A, Delli Castelli D, Fedeli F, Mortillaro A, Nielsen FU, Terreno E,. Paramagnetic lanthanide(III) complexes as pH-sensitive chemical exchange saturation transfer (CEST) contrast agents for MRI applications. Magn Reson Med 2002; 47: 639-648.
24. Aime S, Calabi L, Biondi L,., De Miranda M, Ghelli S, Paleari L, Rebaudengo C, Terreno E,. Iopamidol: exploring the potential use of a well-established X-ray contrast agent for MRI. Magn Reson Med 2005; 53: 830-834.
25. Longo DL, Dastrù W, Digilio G, et al. Iopamidol as a responsive MRI-chemical exchange saturation transfer contrast agent for pH mapping of kidneys: In vivo studies in mice at 7 T. Magn Reson Med 2011; 65: 202-211.
26. Zager RA,. Rhabdomyolysis and myohemoglobinuric acute renal failure. Kidney Int 1996; 49: 314-326.
27. Herrera MB, Bussolati B, Bruno S, Fonsato V, Romanazzi GM, Camussi G,. Int J Mol Med 2004; 14: 1035-1041.
28. Stancanello J, Terreno E, Castelli DD, Cabella C, Uggeri F, Aime S,. Development and validation of a smoothing-splines-based correction method for improving the analysis of CEST-MR images. Contrast Media Mol Imaging 2008; 3: 136-149.
29. Terreno E, Stancanello J, Longo D, Castelli DD, Milone L, Sanders HM, Kok MB, Uggeri F, Aime S,. Methods for an improved detection of the MRI-CEST effect. Contrast Media Mol Imaging 2009; 4: 237-247.
30. Raghunand N, Howison C, Sherry AD, Zhang S, Gillies RJ,. Renal and systemic pH imaging by contrast-enhanced MRI. Magn Reson Med 2003; 49: 249-257.
31. Vinogradov E, He H, Lubag A, Balschi JA, Sherry AD, Lenkinski RE,. MRI detection of paramagnetic chemical exchange effects in mice kidneys in vivo. Magn Reson Med 2007; 58: 650-655.
32. Woodrow G, Brownjohn AM, Turney JH,. The clinical and biochemical features of acute renal failure due to rhabdomyolysis. Ren Fail 1995; 17: 467-474.
33. Laing CM, Toye AM, Capasso G, Unwin RJ,. Renal tubular acidosis: developments in our understanding of the molecular basis. Int J Biochem Cell Biol 2005; 37: 1151-1161.
34. van Zijl PC, Yadav NN,. Chemical exchange saturation transfer (CEST): what is in a name and what isn't? Magn Reson Med 2011; 65: 927-948.